Although clinically significant bioprosthetic valve thrombosis is rare, it should be considered a possible cause of valve dysfunction when there is an increasing transvalvular pressure gradient after anticoagulation is terminated. We describe a rare case of bioprosthetic mitral thrombosis in a 77-year-old woman 2 years after valve replacement and a maze procedure.
NakaoMLimSLChuaYL. Bioprosthetic mitral valve thrombosis in a patient sinus rhythm after the radiofrequency maze procedure. J Thorac Cardiovasc Surg2006; 132: 1464–1465.
2.
SaeedOWilliamsBRJrKuMLattoufOM. Bioprosthetic mitral valve thrombosis less than one year after replacement and an ablative maze procedure: a case report. J Cardiothoracic Surg2010; 5: 18–18.
3.
OliverJMGallegoPGonzalezADominguezFJGamalloCMesaJM. Bioprosthetic mitral valve thrombosis: clinical profile, transesophageal echocardiographic features, and follow-up after anticoagulant therapy. J Am Soc Echocardiogr1996; 9: 691–699.
4.
ThomasBCarrerasFBorrasXPons-LladóG. An unusual case of bioprosthetic mitral valve thrombosis. Ann Thorac Surg2001; 72: 259–261.
5.
AminianALefebvrePDelmottePFriartA. An unusual case of late bioprosthetic mitral valve thrombosis successfully managed with anticoagulation. Eur J Echocardiogr2008; 9: 399–400.
6.
BonowROCarabelloBAChatterjeeKde LeonACJrFaxonDPFreedMD. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol2008; 52: e1–142.
7.
CalkinsHBrugadaJPackerDLCappatoRChenSACrijnsHJ. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm2007; 4: 816–861.
8.
SteinPDAlpertJSDalenJEHorstkotteDTurpieAG. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest1998; 114: 602–602. S–10S.
